Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nabriva (NBRV)
NASDAQ:NBRV
Holding NBRV?
Track your performance easily
NBRV Stock Chart & Stats
Day’s Range$1.35 - $1.9
52-Week Range― - ―
Previous Close$1.42
Volume717.23K
Average Volume (3M)N/A
Market Cap
$3.04M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding3,200,000
10 Day Avg. Volume87,683
30 Day Avg. Volume32,120
Standard Deviation0.23
R-Squared0.12
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-1.04
Price to Sales (P/S)0.60
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nabriva News
PremiumPress Releases
Nabriva Therapeutics Provides Corporate UpdateRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NBRV FAQ
What was Nabriva’s price range in the past 12 months?
Currently, no data Available
What is Nabriva’s market cap?
Currently, no data Available
When is Nabriva’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nabriva’s earnings last quarter?
Currently, no data Available
Is Nabriva overvalued?
According to Wall Street analysts Nabriva’s price is currently Overvalued.
Does Nabriva pay dividends?
Nabriva does not currently pay dividends.
What is Nabriva’s EPS estimate?
Nabriva’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nabriva have?
Currently, no data Available
What happened to Nabriva’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nabriva?
Among the largest hedge funds holding Nabriva’s share is Aisling Capital Management LP. It holds Nabriva’s shares valued at 16K.
---
Company Description
Nabriva
Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company, which engages in the research and development of novel antibiotics to treat serious infections. Its product pipeline includes Lefamulin, CONTEPO, and BC-7013. The company was founded in October 2005 and is headquartered in Dublin, Ireland.
---
NBRV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering NBRV
1 Year
1 Year Success Rate
0/19 ratings generated profit
1 Year Average Return
-71.41%
downgraded a sell rating 2 years ago
Copying Carl Byrnes's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -71.41% per trade.
---